2022-2023 NAVY INFLUENZA VACCINATION AND REPORTING POLICY:
R 171959Z NOV 22 MID200080475819U
FM CNO WASHINGTON DC
INFO CNO WASHINGTON DC
PASS TO OFFICE CODES:
FM CNO WASHINGTON DC//DNS//
INFO CNO WASHINGTON DC//DNS//
MSGID/GENADMIN/CNO WASHINGTON DC//
SUBJ/2022-2023 NAVY INFLUENZA VACCINATION AND REPORTING POLICY//
REF/C/DOC/OFR/32 CFR PART 199.21/01DEC2016//
NARR/REF A IS THE DEPARTMENT OF DEFENSE INSTRUCTION (DODI) 6025.19 INDIVIDUAL
MEDICAL READINESS PROGRAM, ADDRESSING RESPONSIBILITIES AND PROCEDURES FOR
MONITORING AND MAINTAINING INDIVIDUAL MEDICAL READINESS.
REF B IS THE DEFENSE HEALTH AGENCY PROCEDURAL INSTRUCTION (DHA-PI) 6025.34
GUIDANCE FOR THE DOD INFLUENZA VACCINATION PROGRAM (IVP).
REF C IS THE OFFICE OF THE FEDERAL REGISTRAR TITLE 32 OF THE CODE OF FEDERAL
REGULATIONS PART 199.21 (32 CFR PART 199.21), CIVILIAN HEALTH AND MEDICAL
PROGRAM OF THE UNIFORMED SERVICES (CHAMPUS) TRICARE PHARMACY BENEFITS
REF D IS THE BUREAU OF MEDICINE AND SURGERY INSTRUCTION (BUMEDINST) 6230.15B
IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE PREVENTION OF INFECTIOUS
REF E IS A WEEKLY CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) MORBIDITY
AND MORTALITY WEEKLY REPORT (MMWR) REPORT.
REF F IS THE MEDICAL MATERIAL QUALITY CONTROL MESSAGE//
POC/CDR PETER SEGUIN/BUMED FALLS CHURCH VA/(703) 681-9474/EMAIL:
RMKS/1. Influenza (flu) is a contagious viral respiratory illness, which can
cause mild to severe illness resulting in hospitalization or death. Flu has
the potential to adversely impact Navy force readiness and mission execution.
2. Influenza Vaccination and Reporting
a. Influenza Disease Prevention. Vaccination is the primary method to
reduce risk of influenza by enhancing force immunity. Maintaining a clean
work environment, good hygiene practices including cough/sneeze hygiene, and
managing workforce exposure (e.g., social distancing, teleworking, and sick
leave) are effective methods to reduce the risk of spreading influenza.
b. Influenza Vaccine. Two influenza vaccines, Northern Hemisphere (NH)
and Southern Hemisphere (SH), are available based on service member location
and timing requirements as described in reference (b). The 2022-2023
Department of Defense (DoD) influenza season vaccine supply will be comprised
of injectable vaccines. Intranasal vaccine will not be provided through the
central ordering process.
c. Influenza Vaccine Priority. U.S. Navy ships, operational assets, and
training commands have been identified by the DoD and Department of the Navy
(DON) as vaccine priority groups for the 2022-2023 influenza season.
d. Influenza Vaccine Ordering. All Defense Health Agency (DHA) Military
Treatment Facilities (MTFs) will follow the MMQC-22-1438 guidance instructing
them to submit the influenza requirements for their MTFs and the Branch
Health Clinics that they support into the U.S. Army Medical Materiel Agency
ordering portal. All Fleet, USMC units, and reserve commands will continue
to submit their requirements in the Vaccine Information and Logistics System
(VIALS). VIALS is the online requisition system for seasonal influenza
vaccine. VIALS tracks requisitioned vaccine electronically via Military
Standard Requisitioning and Issuing Procedure (MILSTRIP) from requisition to
receipt. The VIALS Web site is common access card enabled:
e. Operational Forces Support, Naval Medical Readiness Logistics Command
(NMRLC), Detachment, Fort Detrick is responsible for ordering and
distributing influenza vaccine for all Navy and Marine Corps activities.
Additional quantities required must be coordinated with the VIALS helpdesk
f. Influenza Vaccine Shipping. All commands will verify their correct
shipping address and point of contact information in VIALS to ensure prompt
g. Influenza Vaccine Integrity
(1) Temperature Monitors. All Influenza vaccine shipments include
temperature monitors. All monitors must be returned to the Defense Logistics
Agency - Troop Support Medical (DLA-TSM) cold chain office after receipt per
the included instructions and shipping materials.
(a) No Alarm Status. The vaccine is ready for immediate use.
(b) Alarmed Status. Do not administer vaccine. Segregate the
vaccine in the refrigerator with a sign saying "DO NOT USE," return
temperature monitor to DLA-TSM, and await disposition.
h. Influenza Vaccine Exercise. Previous influenza seasons have been
used to exercise and evaluate mass vaccination scenarios. These coordinated
mass vaccination campaigns provide rapid and efficient vaccinations to
protect the maximum number of susceptible persons. Process improvements are
made to delivery and reporting procedures based on lessons learned. Ensure
masking, social distancing, group size limitations, and other appropriate
precautions during any mass vaccination exercises, if undertaken, when
i. Vaccine Delivery. Due to vaccine demand and manufacturer
limitations, complete vaccine delivery may be delayed. This delay will
unintentionally test the ability to conduct rapid and complete mass
j. Influenza Vaccination Compliance
(1) Navy Military Personnel. The seasonal influenza vaccination is
mandatory for all DoD uniformed personnel who are not medically or
administratively exempt, per references (a), (b), and (d). Any refusal to
receive the influenza vaccine will constitute a failure to obey a lawful
order and may be punishable under the Uniform Code of Military Justice and/or
result in administrative action. Prior to receiving the influenza vaccine,
Navy Active and Reserve Component personnel will have access to healthcare
providers to address questions or concerns with influenza
vaccination. Commands must consult with the servicing Staff Judge Advocate
General for additional guidance on influenza vaccination non-compliance.
(2) Navy Civilian Personnel. Influenza vaccination is required for
all civilian healthcare personnel as per reference (b), and is strongly
encouraged for all other Navy civilian employees.
(3) TRICARE Beneficiaries. Reference (c) authorizes retail network
pharmacies to administer the seasonal influenza vaccine. TRICARE
beneficiaries may receive influenza vaccinations with no co-pay at authorized
retail network pharmacies. Beneficiaries are encouraged to contact the
pharmacy regarding age restrictions as some pharmacies do not administer the
influenza vaccine to individuals younger than 18 years of age.
k. Influenza Vaccination Reporting. Active and Reserve Component Navy
force vaccination administration compliance will be monitored via the Medical
Readiness Reporting System (MRRS). Designated command personnel will access
MRRS to track their personnel to ensure compliance.
(1) Shore-based commands will request access to MRRS based on their
unit identification code by submitting a system access authorization request
available at: //mrrs.dc3n.navy.mil/mrrs (note: MRRS Web address is case
sensitive). Point of contact: MRRS program office and e-mail:
email@example.com (800) 537-4617 / (504) 697-7070/DSN: 647-7070.
Ship-based commands may utilize Navy Medicine Online (NMO) or Shipboard Non-
Tactical Automated Data Processing Automated Medical System (SAMS) to
(2) Commands must ensure that documentation of influenza vaccine
administration is coded to accurately reflect the type of vaccine given.
(3) Afloat units will enter influenza immunizations into the
Shipboard Automated Medical System / Theater Medical Information Program for
subsequent transfer to MRRS.
(4) All personnel who receive the vaccination from a retail network
pharmacy must provide documentation of vaccination no later than the next
duty or drill day to ensure compliance is appropriately recorded in their
electronic health records and MRRS. The following information will need to
be provided, at a minimum: date vaccine was administered, vaccine name or
code, manufacturer, and lot number.
(5) Vaccination Timeline
(a) Due to the risk of infection transmission within the unit and
impact on operations, it is imperative that the vaccine be given with as
minimal delay as possible. Active duty units have 72 hours (three business
working days) following receipt of the vaccine to document, begin
administering, and report vaccination. The 72-hour requirement begins
immediately only if the temperature monitor is in "no alarm" status upon
receipt; if in "alarmed" status the timed requirement begins once / if the
vaccine is cleared for use by DLA-TSM. If the 72 hour requirement cannot be
met, unit situation reports will be submitted to the respective Immediate
Superior in Command and Type Commanders. Situation reports are not required
if the temperature monitor is in alarmed status and the unit is awaiting
disposition from DLA-TSM.
(b) As Reserve Component Command schedules vary, NMRLC and DLA-
TSM will coordinate to make every effort for the vaccine to arrive the week
of a drill weekend. Units have one drill weekend following receipt of the
vaccine to document, administer, and report vaccination if the temperature
monitor is in a "no alarm" status. If in "alarmed" status, the timed
requirement begins once / if the vaccine is cleared for use by DLA-TSM.
(6) Per paragraph 2.i, uniformed member compliance must be tracked in
MRRS. If desired, installations and MTFs may also use the Navy Family
Accountability and Assessment System (NFAAS) to conduct a Pandemic Influenza
response exercise in conjunction with the seasonal influenza vaccine program.
l. Navy Goals and Performance Standards
(1) To ensure force medical readiness before peak influenza season,
all Navy operational units and Navy Medicine Readiness and Training Commands
/ Units will administer the 2022-2023 influenza vaccination to exceed the 90
percent vaccination goal by 15 December 2022 for Active and Reserve
Components. Complete vaccine access will be provided for all Navy family
members (includes dependents, other beneficiaries, and DoN ivilians). Active
coordination between command leadership, public affairs officers, and medical
personnel is necessary to achieve success.
(2) Influenza Vaccination Performance Standards. The following goals
will be monitored:
(a) Navy VIALS reports 100 percent of shipped vaccine received
onboard by fleet and Navy units by 1 December 2022.
(b) MRRS reports 90 percent of Active and Reserve Component
vaccinated by 15 December 2022. Commands will coordinate with the servicing
MTF to align command-wide vaccinations with Navy vaccination
goals. Medical personnel at servicing MTFs will promptly report vaccinations
m. Vaccine administration and Coronavirus Disease 2019 (COVID -19)
(1) There is no current contraindication for administration of the
influenza vaccination during the COVID-19 pandemic and every effort should be
made to deliver the vaccine as quickly as possible to eligible Service
(2) Personnel who meet criteria to receive a COVID-19 booster dose
are highly encouraged to do so as soon as they are available consistent with
instructions from the CDC and from supporting MTFs.
3. Released by Mr. Andrew S. Haeuptle, Director, Navy Staff.//